Dabomb Protein (6578) — Cash Flow Reinvestment Rate
Dabomb Protein (6578) has a Cash Flow Reinvestment Rate of 3.69x as of March 2025, reinvesting NT$29.94 Million (capex NT$20.59 Million plus investments NT$9.35 Million) from operating cash flow of NT$8.12 Million. Check earnings quality score of Dabomb Protein to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dabomb Protein Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Dabomb Protein across 10 annual periods. Explore Dabomb Protein (6578) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Dabomb Protein (2015–2025)
Year-by-year capital reinvestment analysis for Dabomb Protein. For live market cap and broader valuation context, see Dabomb Protein stock valuation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 3.64x | NT$60.61 Million | NT$16.65 Million | NT$37.69 Million | ▲ +435.7% |
| 2024 | 0.68x | NT$32.32 Million | NT$47.55 Million | NT$30.32 Million | ▼ -91.3% |
| 2023 | 7.80x | NT$50.77 Million | NT$6.51 Million | NT$18.87 Million | ▲ +189.9% |
| 2022 | 2.69x | NT$53.05 Million | NT$19.71 Million | NT$20.16 Million | ▼ -43.4% |
| 2020 | 4.76x | NT$63.80 Million | NT$13.41 Million | NT$18.31 Million | ▲ +69.4% |
| 2019 | 2.81x | NT$93.39 Million | NT$33.26 Million | NT$91.81 Million | ▼ -62.4% |
| 2018 | 7.46x | NT$164.65 Million | NT$22.07 Million | NT$163.06 Million | ▲ +94.3% |
| 2017 | 3.84x | NT$168.40 Million | NT$43.87 Million | NT$166.46 Million | ▲ +27.2% |
| 2016 | 3.02x | NT$179.88 Million | NT$59.58 Million | NT$92.71 Million | ▲ +7354.3% |
| 2015 | 0.04x | NT$5.66 Million | NT$139.78 Million | NT$5.33 Million | — |